United-Guardian(UG) - 2025 Q3 - Quarterly Results

"On a positive note we have made progress with our project to increase sales of Renacidin, our most important pharmaceutical product, by working with an outside pharmaceutical consultant to have Renacidin included on additional drug formularies. We are excited about the potential this project has to significantly increase sales of Renacidin over the coming years. We are hopeful that this project, along with the new marketing agreements we have negotiated recently for some of our new personal care products, ...